| P50 | author | Roberta Fruttero | Q42417799 |
| | Donatella Boschi | Q57123928 |
| P2093 | author name string | Alberto Gasco | |
| | Clara Cena | |
| | Antonella Di Stilo | |
| | Elena Guaita | |
| | Gabriella Coruzzi | |
| | Giuseppina Morini | |
| | Marta Giorgis | |
| | Naveen Chandra Talniya | |
| P2860 | cites work | Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs | Q24672983 |
| | Leukotriene C: a slow-reacting substance from murine mastocytoma cells | Q33972104 |
| | Inflammatory mediators in gastrointestinal defense and injury | Q34462954 |
| | Antiinflammatory and antinociceptive effects of the selective histamine H4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation | Q34611834 |
| | Nitric oxide in respiratory diseases. | Q34874996 |
| | Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea | Q35028147 |
| | Development of 5-lipoxygenase inhibitors--lessons from cellular enzyme regulation | Q36134241 |
| | Leukotriene modifiers as potential therapeutics for cardiovascular disease | Q36205826 |
| | Designed multiple ligands. An emerging drug discovery paradigm | Q36284452 |
| | Therapeutic options for 5-lipoxygenase inhibitors | Q36534370 |
| | Five-lipoxygenase pathway of arachidonic acid metabolism in carcino-genesis and cancer chemoprevention | Q36651760 |
| | Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease | Q36774177 |
| | Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin | Q36972526 |
| | Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases | Q37888849 |
| | Introduction of a nomenclature: Leukotrienes | Q39284498 |
| | The arginine-nitric oxide pathway: a target for new drugs. | Q40386404 |
| | Role of cysteinyl leukotrienes in nociceptive and inflammatory conditions in experimental animals | Q43662490 |
| | Differential effect of zileuton, a 5-lipoxygenase inhibitor, against nociceptive paradigms in mice and rats | Q46527245 |
| | Novel antioxidant agents deriving from molecular combination of Vitamin C and NO-donor moieties | Q46688000 |
| | New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities. | Q48314915 |
| | Release of 15-hydroxy-5,8,11,13-eicosatetraenoic acid and cysteinyl-leukotrienes in carrageenin-induced inflammation: effect of non-steroidal anti-inflammatory drugs | Q68263104 |
| | Synthesis and pharmacological evaluation of (nitrooxy)alkyl apovincaminates | Q70637790 |
| P433 | issue | 9 | |
| P304 | page(s) | 1444-1449 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | ChemMedChem | Q2962252 |
| P1476 | title | Multitarget drugs: synthesis and preliminary pharmacological characterization of zileuton analogues endowed with Dual 5-LO inhibitor and NO-dependent activities | |
| P478 | volume | 5 | |